Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?

Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?

Item
http://www.wikidata.org/entity/Q37898749
Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic reviewEvaluation of the incremental cost to the National Health Service of prescribing analogue insulin.Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trialsMortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetesAssociation between insulin dosage and insulin usage time, and coronary artery lesions in patients with type 2 diabetes and coronary heart diseaseComparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 DiabetesInsulin Dose and Cardiovascular Mortality in the ACCORD Trial.The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern.Beneficial and detrimental effects of glycemic control on cardiovascular disease in type 2 diabetes.Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.Increased mortality risk in diabetic patients discharged from hospital with insulin therapy after an acute myocardial infarction: Data from the FAST-MI 2005 registry.The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A retrospective cohort study.Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?: The time has come for GLP-1 receptor agonists!Insulin as an early treatment for type 2 diabetes: ORIGIN or end of an old question?Randomized Trial of the Effects of Insulin and Metformin on Myocardial Injury and Stress in Diabetes Mellitus: A Post Hoc Exploratory Analysis.The shifting paradigm in the treatment of type 2 diabetes mellitus-A cardiologist's perspective.Relationship between diabetes and ischaemic injury among patients with revascularized ST-elevation myocardial infarction.
P2860

Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?

Item
http://www.wikidata.org/entity/Q37898749
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reducing cardiovascular diseas ...... n be too much of a good thing?
@en
Reducing cardiovascular diseas ...... n be too much of a good thing?
@nl
type
label
Reducing cardiovascular diseas ...... n be too much of a good thing?
@en
Reducing cardiovascular diseas ...... n be too much of a good thing?
@nl
prefLabel
Reducing cardiovascular diseas ...... n be too much of a good thing?
@en
Reducing cardiovascular diseas ...... n be too much of a good thing?
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Reducing cardiovascular diseas ...... n be too much of a good thing?
@en
P2093
P2860
P304
P31
P356
10.1111/J.1463-1326.2011.01468.X
P433
P478
P577
P698
P921